Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1980 Nov;133(5):392–407.

Macroamylasemia and Other Immunoglobulin-Complexed Enzyme Disorders

David C Klonoff 1,2
PMCID: PMC1272350  PMID: 6162278

Abstract

Macroamylase is a circulating complex of immunoglobulin linked to normal amylase in most cases. Its physical properties are heterogeneous, but its large size impairs renal filtration. Macroamylasemia usually causes hyperamylasemia and an amylase clearance:creatinine clearance (CAM:CCR) ratio of less than 1 percent. Macroamylasemia occurs in 2.5 percent of hyperamylasemic patients, and 1 percent of apparently healthy subjects with normal amylase levels. It often accompanies diseases of aberrant immunity or conditions in which pancreatitis must be ruled out. This disorder should be considered in a patient with asymptomatic hyperamylasemia because its detection can obviate a prolonged diagnostic workup. The condition requires no treatment and may be transient. Macroamylasemia is one of several immunoglobulin-complexed enzyme (ICE) disorders. MacroLDemia, an ICE disorder of lactate dehydrogenase (LD), shares features with macroamylasemia. These and other ICE disorders appear to represent nonspecific dysproteinemic responses to disease.

Full text

PDF
392

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. APPELLA E., MARKERT C. L. Dissociation of lactate dehydrogenase into subunits with guanidine hydrochloride. Biochem Biophys Res Commun. 1961 Nov 20;6:171–176. doi: 10.1016/0006-291x(61)90123-1. [DOI] [PubMed] [Google Scholar]
  2. Adlercreutz H., Soininen K., Harkonan M. Oral contraceptives and serum amylase. Br Med J. 1972 Aug 26;3(5825):529–529. doi: 10.1136/bmj.3.5825.529-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ammon R. K. A case of macroamylasaemia. Med J Aust. 1969 Jul 5;2(1):31–33. doi: 10.5694/j.1326-5377.1969.tb105588.x. [DOI] [PubMed] [Google Scholar]
  4. Andersson T. R., Hetland O. Makroamylasemi. Tidsskr Nor Laegeforen. 1975 Sep 10;95(25):1408–1409. [PubMed] [Google Scholar]
  5. Andrews P. The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J. 1965 Sep;96(3):595–606. doi: 10.1042/bj0960595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baba S., Morita S., Mizuno N., Okada K. Letter: Autoimmunity to glucagon in a diabetic not on insulin. Lancet. 1976 Sep 11;2(7985):585–585. doi: 10.1016/s0140-6736(76)91846-8. [DOI] [PubMed] [Google Scholar]
  7. Bachrach W. H., Birsner J. W., Izenstark J. L., Smith V. L. Pancreatic scanning: a review. Gastroenterology. 1972 Nov;63(5):890–910. [PubMed] [Google Scholar]
  8. Barrows D., Berk J. E., Fridhandler L. Macroamylasemia--survey of prevalence in a mixed population. N Engl J Med. 1972 Jun 22;286(25):1352–1352. doi: 10.1056/NEJM197206222862509. [DOI] [PubMed] [Google Scholar]
  9. Berggren T., Levitt M. D. An unusual form of macroamylasemia. Gastroenterology. 1974 Jul;67(1):149–154. [PubMed] [Google Scholar]
  10. Berk J. E., Fridhandler L., Montgomery K. Simulation of macroamylasaemia by salivary-type ('S type') hyperamylasaemia. Gut. 1973 Sep;14(9):726–729. doi: 10.1136/gut.14.9.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Berk J. E., Hayashi S., Searcy R. L., Hightower N. C., Jr Differentiation of parotid and pancreatic amylase in human serum. Am J Dig Dis. 1966 Sep;11(9):695–701. doi: 10.1007/BF02239422. [DOI] [PubMed] [Google Scholar]
  12. Berk J. E., Kizu H., Geller E., Fridhandler L. Macroamylasemia: observations on the nature of the macroamylase. Proc Soc Exp Biol Med. 1969 May;131(1):154–159. doi: 10.3181/00379727-131-33827. [DOI] [PubMed] [Google Scholar]
  13. Berk J. E., Kizu H., Take S., Fridhandler L. Macroamylasemia: clinical and laboratory features. Am J Gastroenterol. 1970 Mar;53(3):211–222. [PubMed] [Google Scholar]
  14. Berk J. E., Kizu H., Take S., Fridhandler L. Macroamylasemia: serum and urine amylase characteristics. Am J Gastroenterol. 1970 Mar;53(3):223–229. [PubMed] [Google Scholar]
  15. Berk J. E., Kizu H., Wilding P., Searcy R. L. Macroamylasemia: a newly recognized cause for elevated serum amylase activity. N Engl J Med. 1967 Nov 2;277(18):941–946. doi: 10.1056/NEJM196711022771801. [DOI] [PubMed] [Google Scholar]
  16. Berk J. E. Macroamylasaemia. Lancet. 1968 Jun 15;1(7555):1317–1317. [PubMed] [Google Scholar]
  17. Bernades P., Corbic M., Jardillier J. C., Schlegel N., Dupuy R. Macroamylasémie Etude de 3 nouveaux cas. Arch Fr Mal App Dig. 1975 Jan-Feb;64(1):47–52. [PubMed] [Google Scholar]
  18. Bernades P., Marsac J., Perruch M., Bismuth H., Jardillier J. C., Bonfils S. La macroamylasémie. Une cause rare d'hyperamylasémie persistante. Presse Med. 1970 Nov 14;78(48):2123–2125. [PubMed] [Google Scholar]
  19. Biewenga J. Complexes of lactate dehydrogenase and immunoglobulin G in human serum. Clin Chim Acta. 1973 Aug 30;47(2):139–147. doi: 10.1016/0009-8981(73)90308-2. [DOI] [PubMed] [Google Scholar]
  20. Biewenga J., Feltkamp T. E. LDH-IgA immunoglobulin complexes in human serum. Clin Chim Acta. 1975 Feb 8;58(3):239–249. doi: 10.1016/0009-8981(75)90443-x. [DOI] [PubMed] [Google Scholar]
  21. Biewenga J., Feltkamp T. E. Lactate dehydrogenase (LDH)-IgG3 immunoglobulin complexes in human serum. Clin Chim Acta. 1975 Oct 15;64(2):101–116. doi: 10.1016/0009-8981(75)90192-8. [DOI] [PubMed] [Google Scholar]
  22. Biewenga J. Serum lactate dehydrogenase isoenzymes linked to immunoglobulin A. Clin Chim Acta. 1972 Sep;40(2):407–414. doi: 10.1016/0009-8981(72)90352-x. [DOI] [PubMed] [Google Scholar]
  23. Biewenga J., Thijs L. G. Lactate dehydrogenase isoenzyme(s) linked to IgA immunoglobulin in a patient with a myocardial infarction. Clin Chim Acta. 1970 Feb;27(2):293–299. doi: 10.1016/0009-8981(70)90347-5. [DOI] [PubMed] [Google Scholar]
  24. Biewenga J., van Loghem E. Antigenic analysis of the IgA component of LDH-IgA immunoglobulin complexes. Clin Chim Acta. 1978 Jan 2;82(1-2):201–204. doi: 10.1016/0009-8981(78)90045-1. [DOI] [PubMed] [Google Scholar]
  25. Bindrich D., Dürr H. K., Bode J. C. Zur Häufigkeit einer Makroamylasämie und zur diagnostischen Wertigkeit des Quotienten Amylase-clearance/Kreatininclearance. Verh Dtsch Ges Inn Med. 1976;82(Pt 1):954–956. [PubMed] [Google Scholar]
  26. Blainey J. D., Northam B. E. Amylase excretion by the human kidney. Clin Sci. 1967 Jun;32(3):377–383. [PubMed] [Google Scholar]
  27. Block M. B., Berk J. E., Fridhandler L. S., Steiner D. F., Rubenstein A. H. Diabetic ketoacidosis associated with mumps virus infection. Occurrence in a patient with macroamylasemia. Ann Intern Med. 1973 May;78(5):663–667. doi: 10.7326/0003-4819-78-5-663. [DOI] [PubMed] [Google Scholar]
  28. Bosseckert H., Winnefeld K., Seidel K. [Macro-amylasaemia with paraproteinemia and the malabsorption syndrome]. Ger Med Mon. 1969 Mar;14(3):133–135. [PubMed] [Google Scholar]
  29. Brohee D., Delcourt A. La macroamylasémie. Acta Gastroenterol Belg. 1977 Sep-Oct;40(9-10):317–328. [PubMed] [Google Scholar]
  30. Chenais F., Fudenberg H. H., Wang A. C. Immunochemical studies of an immunoglobulin M--immunoglobulin G mixed cryoglobulin. Clin Immunol Immunopathol. 1978 Jan;9(1):67–74. doi: 10.1016/0090-1229(78)90122-8. [DOI] [PubMed] [Google Scholar]
  31. Davis J., Berk J. E., Take S., Fridhandler L. Electrophoretic characteristics of macroamylasemic serum. Clin Chim Acta. 1971 Dec;35(2):305–309. doi: 10.1016/0009-8981(71)90198-7. [DOI] [PubMed] [Google Scholar]
  32. De Broe M. E., Mets T. E., Leroux-Roels G. G., Wieme R. J. Occurrence of immunoglobulin G-alkaline phosphatase complexes in human serum. Ann Intern Med. 1979 Jan;90(1):30–35. doi: 10.7326/0003-4819-90-1-30. [DOI] [PubMed] [Google Scholar]
  33. Dreiling D. A., Leichtling J. J., Janowitz H. D. The amylase-creatinine clearance ratio. Diagnostic parameter or physiologic phenomenon? Am J Gastroenterol. 1974 Apr;61(4):290–296. [PubMed] [Google Scholar]
  34. Duane W. C., Frerichs R., Levitt M. D. Simultaneous study of the metabolic turnover and renal excretion of salivary amylase- 125 I and pancreatic amylase- 131 I in the baboon. J Clin Invest. 1972 Jun;51(6):1504–1513. doi: 10.1172/JCI106947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Dürr H. K., Bindrich D., Bode J. C. The frequency of marcroamylasemia and the diagnostic value of the amylase to creatinine clearance ratio in patients with elevated serum amylase activity. Scand J Gastroenterol. 1977;12(6):701–705. doi: 10.3109/00365527709181707. [DOI] [PubMed] [Google Scholar]
  36. Dürr H. K., Bode C., Krupinski R., Bode J. C. A comparison between naturally occurring macroamylasaemia and macroamylasaemia induced by hydroxyethyl-starch. Eur J Clin Invest. 1978 Jun;8(3):189–191. doi: 10.1111/j.1365-2362.1978.tb00835.x. [DOI] [PubMed] [Google Scholar]
  37. Eng L. I. Binding of glucose-6-phosphate dehydrogenase to a serum component. Clin Chim Acta. 1970 May;28(2):365–367. doi: 10.1016/0009-8981(70)90103-8. [DOI] [PubMed] [Google Scholar]
  38. Faro R. S., Trafton H. F., Organ C. H., Jr Macroamylasemia. Surgery. 1977 Nov;82(5):552–554. [PubMed] [Google Scholar]
  39. Farrar W. H., Calkins G. Sensitivity of the amylase-creatinine clearance ratio in acute pancreatitis. Arch Intern Med. 1978 Jun;138(6):958–962. [PubMed] [Google Scholar]
  40. Fish W. W., Mann K. G., Tanford C. The estimation of polypeptide chain molecular weights by gel filtration in 6 M guanidine hydrochloride. J Biol Chem. 1969 Sep 25;244(18):4989–4994. [PubMed] [Google Scholar]
  41. Folling I., Norman N. Hyperglycemia, hypoglycemic attacks, and production of anti-insulin antibodies without previous known immunization. Immunological and functional studies in a patient. Diabetes. 1972 Jul;21(7):814–826. doi: 10.2337/diab.21.7.814. [DOI] [PubMed] [Google Scholar]
  42. Fridhandler L., Berk J. E. Macroamylasemia. Adv Clin Chem. 1978;20:267–286. doi: 10.1016/s0065-2423(08)60024-4. [DOI] [PubMed] [Google Scholar]
  43. Fridhandler L., Berk J. E., Montgomery K. Nature of isoamylases released, by acidification, from macroamylase complexes. Clin Chem. 1974;20(1):26–29. [PubMed] [Google Scholar]
  44. Fridhandler L., Berk J. E., Ueda M. Isolation and measurement of pancreatic amylase in human serum and urine. Clin Chem. 1972 Dec;18(12):1493–1497. [PubMed] [Google Scholar]
  45. Fridhandler L., Berk J. E., Ueda M. Macroamylasemia: rapid detection method. Clin Chem. 1971 May;17(5):423–426. [PubMed] [Google Scholar]
  46. Fridhandler L., Berk J. E., Wong D. Affinity characteristics of amylase-binding substance(s) prepared from macroamylase complexes. Clin Chem. 1974;20(1):22–25. [PubMed] [Google Scholar]
  47. Fujiki T., Mio A., Hashimoto H., Cho M., Takahashi K. [A case of macroamylasemia and review of the literature (author's transl)]. Nihon Shokakibyo Gakkai Zasshi. 1977 Sep;74(9):1195–1202. [PubMed] [Google Scholar]
  48. Ganrot P. O. Lupoid cirrhosis with serum lactic acid dehydrogenase linked to an gamma A immunoglobulin. Experientia. 1967 Jul 15;23(7):593–593. doi: 10.1007/BF02137992. [DOI] [PubMed] [Google Scholar]
  49. Golde D. W., Greipp P. R., McGinniss M. H. Spectrum of albumin auto-agglutinins. Transfusion. 1973 Jan-Feb;13(1):1–5. doi: 10.1111/j.1537-2995.1973.tb05428.x. [DOI] [PubMed] [Google Scholar]
  50. Hansen H. R., Van Kley H., Knight W. A., Jr Macroamylasemia due to binding by protein. Am J Med. 1972 May;52(5):712–720. doi: 10.1016/0002-9343(72)90062-9. [DOI] [PubMed] [Google Scholar]
  51. Harada K., Nakayama T., Kitamura M., Sugimoto T. Immunological and electrophoretical approaches to macroamylase analysis. Clin Chim Acta. 1975 Mar 24;59(3):291–299. doi: 10.1016/0009-8981(75)90004-2. [DOI] [PubMed] [Google Scholar]
  52. Hayashi S., Noma K., Kobayashi R., Kosaka K. Macromolecular lactate dehydrogenase linked to serum IgG of a patient with liver cirrhosis. Acta Med Okayama. 1976 Apr;30(2):75–86. [PubMed] [Google Scholar]
  53. Hedger R. W., Hardison W. G. Transient macroamylasemia during an exacerbation of acute intermittent porphyria. Gastroenterology. 1971 May;60(5):903–908. [PubMed] [Google Scholar]
  54. Hegarty J. E., O'Donnell M. D., McGeeney K. F., Fitzgerald O. Pancreatic and salivary amylase/creatinine clearance ratios in normal subjects and in patients with chronic pancreatitis. Gut. 1978 May;19(5):350–354. doi: 10.1136/gut.19.5.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Helfat A., Berk J. E., Fridhandler L. The prevalence of macroamylasemia. Further study. Am J Gastroenterol. 1974 Jul;62(1):54–58. [PubMed] [Google Scholar]
  56. Henderson A. R., King J., Imrie C. W. Anomalous response of macroamylase to assay temperature. Clin Chem. 1973 Jan;19(1):123–124. [PubMed] [Google Scholar]
  57. Hirata Y., Tominaga M., Ito J. I., Noguchi A. Spontaneous hypoglycemia with insulin autoimmunity in Graves' disease. Ann Intern Med. 1974 Aug;81(2):214–218. doi: 10.7326/0003-4819-81-2-214. [DOI] [PubMed] [Google Scholar]
  58. Hossaini A. A., Sr Selected topics in immunohematology: II. Albumin autoagglutination phenomenon (antibodies to albumin-bound caprylate). Prog Clin Pathol. 1978;7:178–182. [PubMed] [Google Scholar]
  59. Imrie C. W., King J., Henderson A. R. Macroamylasaemia: a report of two cases. Scott Med J. 1973 Nov;18(6):188–191. doi: 10.1177/003693307301800603. [DOI] [PubMed] [Google Scholar]
  60. Imrie C. W., King J., Henderson A. R. Macroamylasemia--survey of prevalence in a mixed population. N Engl J Med. 1972 Nov 2;287(18):931–931. doi: 10.1056/NEJM197211022871813. [DOI] [PubMed] [Google Scholar]
  61. Johnson S. G., Ellis C. J., Levitt M. D. Mechanism of increased renal clearnace of amylase/creatinine in acute pancreatitis. N Engl J Med. 1976 Nov 25;295(22):1214–1217. doi: 10.1056/NEJM197611252952202. [DOI] [PubMed] [Google Scholar]
  62. KREUTZER H. H. LACTATE DEHYDROGENASE ISOENZYMES: IRREGULARITIES IN ELECTROPHORETIC MOBILITY. Clin Chim Acta. 1965 Feb;11:159–169. doi: 10.1016/0009-8981(65)90210-x. [DOI] [PubMed] [Google Scholar]
  63. Kaczmarek M. J., Rosenmund H. The role of gamma-globulin in composition of macroamylase. Clin Chim Acta. 1977 Aug 15;79(1):183–187. doi: 10.1016/0009-8981(77)90476-4. [DOI] [PubMed] [Google Scholar]
  64. Kajita Y., Majima T., Yoshimura M., Hachiya T., Miyazaki T., Ijichi H., Ochi Y. Demonstration of antibody for glutamic pyruvic transaminase (GPT) in chronic hepatic disorders. Clin Chim Acta. 1978 Nov 1;89(3):485–492. doi: 10.1016/0009-8981(78)90414-x. [DOI] [PubMed] [Google Scholar]
  65. Kanno T., Sudo K. Properties of amylase-linked immunoglobulins. Clin Chim Acta. 1977 Apr 1;76(1):67–77. doi: 10.1016/0009-8981(77)90119-x. [DOI] [PubMed] [Google Scholar]
  66. Kellner R., Horstmann H. J., Flügel M., Tympner F. Zur Diagnostik der Makroamylasämie. Dtsch Med Wochenschr. 1974 Sep 6;99(36):1772–1773. doi: 10.1055/s-0028-1108046. [DOI] [PubMed] [Google Scholar]
  67. Kindmark C. O. Atypical lactate dehydrogenase isoenzyme pattern caused by immunoglobulin G interaction. Scand J Clin Lab Invest. 1969 Aug;24(1):49–53. doi: 10.3109/00365516909080131. [DOI] [PubMed] [Google Scholar]
  68. Kitamura T., Yoshioka K., Ehara M., Akedo H. A study on the nature of macroamylase complex. Dissociation of macroamylase by substrates. Gastroenterology. 1977 Jul;73(1):46–51. [PubMed] [Google Scholar]
  69. Kobayashi T., Nakayama T., Kitamura M. Electrophoretic identification of serum immunoglobulins linked to amylase:macroamylase. Clin Chim Acta. 1978 Jun 15;86(3):261–265. doi: 10.1016/0009-8981(78)90380-7. [DOI] [PubMed] [Google Scholar]
  70. Köhler H., Kirch W., Horstmann H. J. Die Bildung hochmolekularer Komplexe aus Serumamylase und kolloidalen Plasmaersatzmitteln. Anaesthesist. 1977 Nov;26(11):623–627. [PubMed] [Google Scholar]
  71. Köhler H., Kirch W., Horstmann H. J. Hydroxyethyl starch-induced macroamylasemia. Int J Clin Pharmacol Biopharm. 1977 Sep;15(9):428–431. [PubMed] [Google Scholar]
  72. Köhler H., Kirch W., Weihrauch T. R., Prellwitz W., Horstmann H. J. Macroamylasaemia after treatment with hydroxyethyl starch. Eur J Clin Invest. 1977 Jun;7(3):205–211. doi: 10.1111/j.1365-2362.1977.tb01599.x. [DOI] [PubMed] [Google Scholar]
  73. Laurell C. B., Thulin E. Complexes in plasma between light chain kappa immunoglobulins and alpha 1-antitrypsin respectively prealbumin. Immunochemistry. 1974 Nov;11(11):703–709. doi: 10.1016/0019-2791(74)90269-9. [DOI] [PubMed] [Google Scholar]
  74. Lenkei R., Ghetie V. Methods for detection of anti-albumin autoantibodies in hepatic diseases. J Immunol Methods. 1977;16(1):23–30. doi: 10.1016/0022-1759(77)90036-9. [DOI] [PubMed] [Google Scholar]
  75. Levine R. I., Glauser F. L., Berk J. E. Enhancement of the amylase-creatinine clearance ratio in disorders other than acute pancreatitis. N Engl J Med. 1975 Feb 13;292(7):329–332. doi: 10.1056/NEJM197502132920702. [DOI] [PubMed] [Google Scholar]
  76. Levitt M. D., Cooperband S. R. Hyperamylasemia from the binding of serum amylase by an 11S IgA globulin. N Engl J Med. 1968 Feb 29;278(9):474–479. doi: 10.1056/NEJM196802292780903. [DOI] [PubMed] [Google Scholar]
  77. Levitt M. D., Duane W. C., Cooperband S. R. Study of macroamylase complexes. J Lab Clin Med. 1972 Sep;80(3):414–422. [PubMed] [Google Scholar]
  78. Levitt M. D., Goetzl E. J., Cooperband S. R. Two forms of macroamylasaemia. Lancet. 1968 May 4;1(7549):957–958. doi: 10.1016/s0140-6736(68)90907-0. [DOI] [PubMed] [Google Scholar]
  79. Levitt M. D., Johnson S. G., Ellis C. J., Engel R. R. Influence of amylase assay technique on renal clearance of amylase-creatinine ratio. Gastroenterology. 1977 Jun;72(6):1260–1263. [PubMed] [Google Scholar]
  80. Levitt M. D., Rapoport M., Cooperband S. R. The renal clearance of amylase in renal insufficiency, acute pancreatitis, and macroamylasemia. Ann Intern Med. 1969 Nov;71(5):919–925. doi: 10.7326/0003-4819-71-5-919. [DOI] [PubMed] [Google Scholar]
  81. Lindström P., Wager O. IgG autoantibody to human serum albumin studied by the ELISA-technique. Scand J Immunol. 1978;7(5):419–425. doi: 10.1111/j.1365-3083.1978.tb00472.x. [DOI] [PubMed] [Google Scholar]
  82. Long W. B., Grider J. R., Jr Amylase isoenzyme clearances in normal subjects and in patients with acute pancreatitis. Gastroenterology. 1976 Oct;71(4):589–593. [PubMed] [Google Scholar]
  83. Long W. B., Kowlessar O. D. A rapid thin layer test for macroamylase with observations on the nature of macroamylase in six patients. Gastroenterology. 1972 Oct;63(4):564–571. [PubMed] [Google Scholar]
  84. Loyter A., Schramm M. Multimolecular complexes of alpha-amylase with glycogen limit dextrin. Number of binding sites of the enzyme and size of the complexes. J Biol Chem. 1966 Jun 10;241(11):2611–2617. [PubMed] [Google Scholar]
  85. Lundh B. A macromolecular serum lactate dehydrogenase activity in a case of leukemia. Clin Chim Acta. 1967 May;16(2):305–309. doi: 10.1016/0009-8981(67)90196-9. [DOI] [PubMed] [Google Scholar]
  86. Mannik M. Binding of albumin to gamma-A-myeloma proteins and Waldenström macroglobulins by disulfide bonds. J Immunol. 1967 Nov;99(5):899–906. [PubMed] [Google Scholar]
  87. Mark L. K., McCord R. G. Pancreatic scanning in diagnosis of macroamylasemia: case report. J Nucl Med. 1977 Feb;18(2):130–132. [PubMed] [Google Scholar]
  88. Markel S. F., Janich S. L. Complexing of lactate dehydrogenase isoenzymes with immunoglobulin A of the kappa class. Am J Clin Pathol. 1974 Mar;61(3):328–332. doi: 10.1093/ajcp/61.3.328. [DOI] [PubMed] [Google Scholar]
  89. Marten A., Beales D., Elias E. Mechanism and specificity of increased amylase/creatinine clearance ratio in pancreatitis. Gut. 1977 Sep;18(9):703–708. doi: 10.1136/gut.18.9.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Meaney R. F., Carey W. F., Pollard A. C. A transient variant of serum lactate dehydrogenase isoenzymes. Clin Chim Acta. 1976 Nov 15;73(1):127–133. doi: 10.1016/0009-8981(76)90314-4. [DOI] [PubMed] [Google Scholar]
  91. Merritt A. D., Karn R. C. The human alpha-amylases. Adv Hum Genet. 1977;8:135–234. [PubMed] [Google Scholar]
  92. Merritt A. D., Rivas M. L., Bixler D., Newell R. Salivary and pancreatic amylase: electrophoretic characterizations and genetic studies. Am J Hum Genet. 1973 Sep;25(5):510–522. [PMC free article] [PubMed] [Google Scholar]
  93. Miller M. E. Host defenses in the human neonate. Pediatr Clin North Am. 1977 May;24(2):413–423. doi: 10.1016/s0031-3955(16)33428-9. [DOI] [PubMed] [Google Scholar]
  94. Mulhausen R., Brown D. C., Onstad G. Renal clearance of amylase during pancreatitis. Metabolism. 1969 Aug;18(8):669–674. doi: 10.1016/0026-0495(69)90080-8. [DOI] [PubMed] [Google Scholar]
  95. Murray W. R., Mackay C. The amylase creatinine clearance ratio in acute pancreatitis. Br J Surg. 1977 Mar;64(3):189–191. doi: 10.1002/bjs.1800640311. [DOI] [PubMed] [Google Scholar]
  96. Musiani P., Lauriola L., Piantelli M. Inhibitory activity of alpha-1-antitrypsin bound to human IgA. Clin Chim Acta. 1978 Apr 3;85(1):61–66. doi: 10.1016/0009-8981(78)90101-8. [DOI] [PubMed] [Google Scholar]
  97. Naeije D. B., van Melsen A., Delcourt A. Macroamylasémie. A propos d'un cas. Acta Gastroenterol Belg. 1977 Sep-Oct;40(9-10):353–359. [PubMed] [Google Scholar]
  98. Nagamine M. Lactate dehydrogenase isoenzymes linked to immunoglobulin A in two cases. Clin Chim Acta. 1972 Jan;36(1):139–144. doi: 10.1016/0009-8981(72)90169-6. [DOI] [PubMed] [Google Scholar]
  99. Nagamine M., Okuma S. Serum alkaline phosphatase isoenzymes linked to immunoglobulin G. Clin Chim Acta. 1975 Nov 15;65(1):39–46. doi: 10.1016/0009-8981(75)90332-0. [DOI] [PubMed] [Google Scholar]
  100. O'Donnell M. D., FitzGerald O., McGeeney K. F. Differential serum amylase determination by use of an inhibitor, and design of a routine procedure. Clin Chem. 1977 Mar;23(3):560–566. [PubMed] [Google Scholar]
  101. Ojala K., Harmoinen A. Determination of amylase activity and amylase isoenzymes in serum and urine using a solid phase blue starch substrate. Scand J Clin Lab Invest. 1975 Mar;35(2):163–169. [PubMed] [Google Scholar]
  102. Pasternack A., Klockars M. Clearance ratios of amylase and isoamylase to creatinine in renal disease. Clin Nephrol. 1978 Jan;9(1):25–28. [PubMed] [Google Scholar]
  103. Peeters T. L., Vantrappen G. R. A screening technique for macroamylasemia using thin-layer gel filtration. Clin Chim Acta. 1973 Sep 14;47(3):437–441. doi: 10.1016/0009-8981(73)90277-5. [DOI] [PubMed] [Google Scholar]
  104. Rajewsky K., Rottländer E., Peltre G., Müller B. The immune response to a hybrid protein molecule; specificity of secondary stimulation and of tolerance induction. J Exp Med. 1967 Oct 1;126(4):581–606. doi: 10.1084/jem.126.4.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Rothenberger W., Patzkewitsch L., Weber K. H. Makroamylasämie. Bericht über zwei Fälle. Dtsch Med Wochenschr. 1975 Aug 1;100(31):1599–1601. doi: 10.1055/s-0028-1106429. [DOI] [PubMed] [Google Scholar]
  106. STEIN E. A., FISCHER E. H. Bacillus subtilis alpha-amylase, a zinc-protein complex. Biochim Biophys Acta. 1960 Apr 8;39:287–296. doi: 10.1016/0006-3002(60)90165-7. [DOI] [PubMed] [Google Scholar]
  107. Salt W. B., 2nd, Schenker S. Amylase--its clinical significance: a review of the literature. Medicine (Baltimore) 1976 Jul;55(4):269–289. doi: 10.1097/00005792-197607000-00001. [DOI] [PubMed] [Google Scholar]
  108. Schiffer C. F., Burke J. F., Jr, Besarab A., Lasker N., Simenhoff M. L. Amylase/creatinine clearance fraction in patients on chronic hemodialysis. Ann Intern Med. 1977 Jan;86(1):65–66. doi: 10.7326/0003-4819-86-1-65. [DOI] [PubMed] [Google Scholar]
  109. Shakib F., Stanworth D. R. Antigammaglobulin (rheumatoid factor) activity of human IgG subclasses. Ann Rheum Dis. 1978 Feb;37(1):12–17. doi: 10.1136/ard.37.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Spiegel M., Oelz O., Knob M., Binswanger U. Makroamylase als seltene ursache der Hyperamylasämie. Klin Wochenschr. 1972 Jun 1;50(11):548–551. doi: 10.1007/BF01487722. [DOI] [PubMed] [Google Scholar]
  111. Stein A. M. Macroamylasemia. Postgrad Med. 1974 Jun;55(6):103–105. doi: 10.1080/00325481.1974.11713786. [DOI] [PubMed] [Google Scholar]
  112. Sudo K., Kanno T. Sialic acid containing abnormal amylases in human sera. Clin Chim Acta. 1975 Nov 3;64(3):303–306. doi: 10.1016/0009-8981(75)90358-7. [DOI] [PubMed] [Google Scholar]
  113. Take S., Fridhandler L., Berk J. E. Macroamylasemia: possible role of polysaccharide in composition of macroamylase. Clin Chim Acta. 1970 Feb;27(2):369–371. doi: 10.1016/0009-8981(70)90364-5. [DOI] [PubMed] [Google Scholar]
  114. Tanaka F., Amino N., Hayashi C., Miyai K., Kumahara Y. Abnormal serum lactate dehydrogenase isoenzyme in a case of laryngeal carcinoma and thyrotoxicosis. Clin Chim Acta. 1976 May 3;68(3):235–240. doi: 10.1016/0009-8981(76)90386-7. [DOI] [PubMed] [Google Scholar]
  115. Tedesco F. J., Harter H. R., Alpers D. H. Serum amylase determinations and amylase to creatinine clearance ratios in patients with chronic renal insufficiency. Gastroenterology. 1976 Oct;71(4):594–598. [PubMed] [Google Scholar]
  116. Thomas D. W., Rosen S. W., Kahn C. R., Temple R., Papadopoulos N. M. Macromolecular lactic acid dehydrogenase. A cause of increased serum lactate dehydrogenase activity. Ann Intern Med. 1974 Oct;81(4):434–439. doi: 10.7326/0003-4819-81-4-434. [DOI] [PubMed] [Google Scholar]
  117. Tomasi T. B., Jr, Hauptman S. P. The binding of alpha-1 antitrypsin to human IgA. J Immunol. 1974 Jun;112(6):2274–2277. [PubMed] [Google Scholar]
  118. Tompkins R. K., Adams J. R. Macroamylasemia in the postoperative patient. A source of confusion and concern. Arch Surg. 1972 Oct;105(4):630–632. doi: 10.1001/archsurg.1972.04180100075017. [DOI] [PubMed] [Google Scholar]
  119. Touboul J. P., Hadchouel P., Hirsh-Marie H., Caroli J., Renault H. [Macroamylasemia associated with malabsorption and cryoglobulinemia. Clinical and biological study of a new case]. Med Chir Dig. 1974;3(6):419–426. [PubMed] [Google Scholar]
  120. Ueda M., Berk J. E., Fridhandler L., Davis J. Ultracentrifugal characteristics of macroamylasemic serum. Clin Chim Acta. 1971 Dec;35(2):299–304. doi: 10.1016/0009-8981(71)90197-5. [DOI] [PubMed] [Google Scholar]
  121. Ueda M., Berk J. E., Fridhandler L. Macroamylasemia: variation in the response of the macroamylase complex to acidification. Proc Soc Exp Biol Med. 1971 Sep;137(4):1152–1156. doi: 10.3181/00379727-137-35745. [DOI] [PubMed] [Google Scholar]
  122. Ueda M., Fujii M., Nakashima Y., Hirata H., Ito J. [Hyperamylasemia of unknown etiology]. Nihon Shokakibyo Gakkai Zasshi. 1975 Apr;72(4):407–413. [PubMed] [Google Scholar]
  123. Urdal P., Landaas S. Macro creatine kinase BB in serum, and some data on its prevalence. Clin Chem. 1979 Mar;25(3):461–465. [PubMed] [Google Scholar]
  124. Vaerman J. P., Fudenberg H. H., Vaerman C., Mandy W. J. On the significance of the heterogeneity in molecular size of human serum gamma A-globulins. Immunochemistry. 1965 Sep;2(3):263–272. doi: 10.1016/0019-2791(65)90006-6. [DOI] [PubMed] [Google Scholar]
  125. Voigt A. Uber eine Besonderheit des LDH-Isoenzyms 3 im Serum. Z Klin Chem Klin Biochem. 1967 May;5(3):146–147. [PubMed] [Google Scholar]
  126. WILDING P. USE OF GEL FILTRATION IN THE STUDY OF HUMAN AMYLASE. Clin Chim Acta. 1963 Nov;8:918–924. doi: 10.1016/0009-8981(63)90016-0. [DOI] [PubMed] [Google Scholar]
  127. Warshaw A. L., Fuller A. F., Jr Specificity of increased renal clearance of amylase in diagnosis of acute pancreatitis. N Engl J Med. 1975 Feb 13;292(7):325–328. doi: 10.1056/NEJM197502132920701. [DOI] [PubMed] [Google Scholar]
  128. Warshaw A. L., Lee K. H. Characteristic alterations of serum isoenzymes of amylase in diseases of liver, pancreas, salivary gland, lung, and genitalia. J Surg Res. 1977 Apr;22(4):362–369. doi: 10.1016/0022-4804(77)90158-5. [DOI] [PubMed] [Google Scholar]
  129. Warshaw A. L., Lee K. H. Macroamylasemia and other chronic nonspecific hyperamylasemias: chemical oddities or clinical entities? Am J Surg. 1978 Apr;135(4):488–493. doi: 10.1016/0002-9610(78)90025-9. [DOI] [PubMed] [Google Scholar]
  130. Warshaw A. L., Lee K. H. The mechanism of increased renal clearance of amylase in acute pancreatitis. Gastroenterology. 1976 Sep;71(3):388–391. [PubMed] [Google Scholar]
  131. Warshaw A. L., Lesser P. B. Amylase clearance in differentiating acute pancreatitis from peptic ulcer with hyperamylasemia. Ann Surg. 1975 Mar;181(3):314–316. doi: 10.1097/00000658-197503000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Wass M., McCann K., Bagshawe K. D. Isolation of antibodies to HCG/LH from human sera. Nature. 1978 Jul 27;274(5669):369–370. doi: 10.1038/274368a0. [DOI] [PubMed] [Google Scholar]
  133. Wilding P., Geokas M. C., Haverback B. J., Stanworth D. R. Hyperamylasemia due to protein-bound amylase. Am J Med. 1969 Sep;47(3):492–496. doi: 10.1016/0002-9343(69)90233-2. [DOI] [PubMed] [Google Scholar]
  134. Yamaguchi N., Kimoto M., Ohomi H., Inoue H., Aoike A. [A case of macroamylasemia (author's transl)]. Nihon Shokakibyo Gakkai Zasshi. 1977 Jun;74(6):802–808. [PubMed] [Google Scholar]
  135. Yoshida A., Toda Y. [A case of macroamylasemia (author's transl)]. Nihon Naika Gakkai Zasshi. 1976 Aug 10;65(8):785–789. [PubMed] [Google Scholar]
  136. Zeze F., Nakamura K., Yoshimori M., Ishii K. Macroamylasemia: clinical and laboratory features in 7 patients. Gastroenterol Jpn. 1975;10(4):255–260. doi: 10.1007/BF02776355. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES